The treatment of hypertension: new lamps for old?

Cardiovascular Drugs and Therapy
J R Hampton


Meta-analysis of clinical trials does not help the clinician to treat individual patients. A general conclusion that the reduction of high blood pressure is beneficial has to be matched by specific information about the level of blood pressure that is acceptable and about the effect of particular doses of specific drugs. Results obtained from trials of "old-fashioned" antihypertensive drugs cannot confidently be extrapolated to "modern" agents. Sufficient data do not exist to encourage universal drug treatment for patients with "mild" hypertension.


Aug 18, 1990·BMJ : British Medical Journal·S WesselyB Cox
May 1, 1989·Hypertension·J A CutlerC D Furberg
Mar 14, 1987·Lancet·J M CruickshankF J Zacharias
Jul 5, 1986·British Medical Journal·D E Grobbee, A Hofman
Jul 1, 1985·Postgraduate Medical Journal·H A Cameron, L E Ramsay
Jul 30, 1988·BMJ : British Medical Journal·J D Swales
Oct 11, 1985·JAMA : the Journal of the American Medical Association·E B KeelerJ P Newhouse
Sep 18, 1982·British Medical Journal·R G WilcoxI A Macdonald

❮ Previous
Next ❯


Dec 1, 1992·Cardiovascular Drugs and Therapy·P Lund-Johansen
Jan 1, 1993·Kyklos : Jahrbuch des Instituts für Geschichte der Medizin an der Universität Leipzig·R J Brent

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.